SLC6A3 and Parkinson disease: Neuroimaging studies with 123I-FP-CIT SPECT, SPECT with TRODAT-1 or PET have explored anxiety severity in PD patients by assessing dopamine transporter (DAT) availability or density [6–9, 25, 26].